| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
37,070,000 |
| Market
Cap: |
2.35(B) |
| Last
Volume: |
12,537,091 |
Avg
Vol: |
5,842,868 |
| 52
Week Range: |
$63.44 - $63.44 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Graham Ginger L |
Director |
– • – |
2019-07-01 |
4 |
A |
$58.86 |
$12,478 |
I/I |
212 |
53,119 |
|
- |
|
| Baker Bros. Investments, L.p. |
Director |
– • • |
2019-06-14 |
4 |
A |
$0.00 |
$0 |
I/I |
11,460 |
7,641,248 |
|
- |
|
| Cohen Fred E |
Director |
– • – |
2019-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
955 |
68,723 |
|
- |
|
| Parker Geoffrey M. |
Director |
– • – |
2019-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
955 |
955 |
|
- |
|
| Graham Ginger L |
Director |
– • – |
2019-06-14 |
4 |
A |
$0.00 |
$0 |
I/I |
955 |
52,907 |
|
- |
|
| Fuchs Henry J |
Director |
– • – |
2019-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
955 |
7,436 |
|
- |
|
| Shak Steven |
Chief Scientific Officer |
• – – |
2019-06-14 |
4 |
AS |
$51.54 |
$545,003 |
I/I |
(10,550) |
233,795 |
|
- |
|
| Shak Steven |
Chief Scientific Officer |
• – – |
2019-06-14 |
4 |
OE |
$31.12 |
$328,316 |
I/I |
10,550 |
244,345 |
|
- |
|
| Shak Steven |
Chief Scientific Officer |
• – – |
2019-06-13 |
4 |
AS |
$51.93 |
$1,298,572 |
I/I |
(25,000) |
233,795 |
|
- |
|
| Shak Steven |
Chief Scientific Officer |
• – – |
2019-06-13 |
4 |
OE |
$31.12 |
$778,000 |
I/I |
25,000 |
258,795 |
|
- |
|
| Shak Steven |
Chief Scientific Officer |
• – – |
2019-06-12 |
4 |
AS |
$51.34 |
$1,283,478 |
I/I |
(25,000) |
233,479 |
|
- |
|
| Shak Steven |
Chief Scientific Officer |
• – – |
2019-06-12 |
4 |
OE |
$30.84 |
$773,768 |
I/I |
25,000 |
258,479 |
|
- |
|
| Cole G Bradley |
CFO |
• – – |
2019-06-11 |
4 |
AS |
$51.30 |
$257,281 |
I/I |
(5,000) |
43,722 |
|
- |
|
| Cole G Bradley |
CFO |
• – – |
2019-06-11 |
4 |
OE |
$17.18 |
$85,900 |
I/I |
5,000 |
48,722 |
|
- |
|
| Shak Steven |
Chief Scientific Officer |
• – – |
2019-06-11 |
4 |
AS |
$51.27 |
$1,285,702 |
I/I |
(25,000) |
233,479 |
|
- |
|
| Shak Steven |
Chief Scientific Officer |
• – – |
2019-06-11 |
4 |
OE |
$30.84 |
$772,278 |
I/I |
25,000 |
258,479 |
|
- |
|
| Vaughn James J |
Chief Commercial Officer |
• – – |
2019-06-06 |
4 |
AS |
$52.25 |
$458,829 |
D/D |
(8,745) |
16,175 |
|
- |
|
| Vaughn James J |
Chief Commercial Officer |
• – – |
2019-06-06 |
4 |
OE |
$31.12 |
$140,040 |
D/D |
4,500 |
24,920 |
|
- |
|
| Popovits Kimberly J |
President and CEO |
• • – |
2019-05-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
800 |
108,152 |
|
- |
|
| Vaughn James J |
Chief Commercial Officer |
• – – |
2019-05-08 |
4 |
AS |
$57.08 |
$420,730 |
D/D |
(7,244) |
20,420 |
|
- |
|
| Vaughn James J |
Chief Commercial Officer |
• – – |
2019-05-08 |
4 |
OE |
$31.12 |
$140,040 |
D/D |
4,500 |
27,664 |
|
- |
|
| Shak Steven |
Chief Scientific Officer |
• – – |
2019-05-08 |
4 |
AS |
$56.97 |
$1,447,616 |
I/I |
(25,000) |
233,479 |
|
- |
|
| Baker Bros. Investments Ii, L.p. |
Director |
– • • |
2019-04-12 |
4 |
S |
$65.32 |
$731,889 |
I/I |
(11,204) |
7,639,338 |
|
- |
|
| Baker Bros. Investments Ii, L.p. |
Director |
– • • |
2019-04-12 |
4 |
S |
$64.62 |
$18,770,153 |
I/I |
(287,465) |
7,648,570 |
|
- |
|
| Baker Bros. Investments Ii, L.p. |
Director |
– • • |
2019-04-11 |
4 |
S |
$66.61 |
$13,533,253 |
I/I |
(202,281) |
7,885,430 |
|
- |
|
1769 Records found
|
|
Page 4 of 71 |
|
|
